BioDetection Systems is proud to be a partner in the major (30 Million €) H2020-supported collaborative project  on toxicological risk assessment: “An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century” (EU-ToxRisk). In this project  academia joins forces with small and medium-sized enterprises (SMEs), large industry, contract research organisations (CROs) and regulatory bodies to achieve a paradigm shift in toxicology towards a more efficient and animal-free chemical safety assessment. These new concepts involve cutting-edge human-relevant in vitro non-animal methods and in silico computational technologies to translate molecular mechanistic understanding of toxicity into safety testing strategies. The workflow is arranged in such a way that cost-effective in silico and in high throughput in vitro methods (such as BDS’ CALUX methods) precede more complicated methods, avoiding unnecessarily complex and costly testing procedures. From project’s start, a unique integrated strategy to exploit and disseminate the consortium tools and knowledge is in place, as described in a separate workpackage, led by BDS. For further details see www.eu-toxrisk.eu